OBJECTIVES: Several preclinical and observational studies have shown that anti-diabetic
medications (ADMs) may modify the risk of pancreatic cancer (PaC). We performed a …

BACKGROUND & AIMS: Antidiabetic drugs have been found to have various effects on
cancer in experimental systems and in epidemiologic studies, although the association …

Diabetes medications may modify the risk of certain cancers. We systematically searched
MEDLINE, Embase, Web of Science, and Cochrane CENTRAL from 2011 to March 2021 for …

This study investigated the effects of diabetes and antidiabetic medications on the risk of
pancreatic cancer (PaC). We extracted data on Koreans with newly diagnosed diabetes and …

OBJECTIVES: The objective of this study was to explore the association between use of
metformin or other antidiabetic drugs, diabetes, and the risk of pancreatic cancer …

Background Type 2 diabetes mellitus has been associated with an excess risk of pancreatic
cancer, but the magnitude of the risk and the time–risk relationship are unclear, and there is …

Background and aims: Hypoglycemic agents are the primary therapeutic approach for the
treatment of diabetes and have been postulated to impact pancreatic cancer (PC) incidence …

Objective We aim to evaluate the relationship between the use of metformin and the risk of
pancreatic cancer in type 2 diabetes patients. Method We systematically searched the …

BACKGROUND: Diabetes mellitus (DM) is widely considered to be associated with risk of
pancreatic cancer (PaC), however, whether DM is a cause or a consequence of PaC is still …

OBJECTIVE There are no specific treatment guidelines for diabetes of the exocrine
pancreas. High-quality studies are warranted to investigate whether the use of antidiabetic …